6 December 2021
The regulatory framework for the issuance of insurance-linked securities in Hong Kong is now in place with the amendments to the Insurance Ordinance having commenced operation on 29 March 2021.
The amendments to the Insurance Ordinance (Cap. 41, Laws of Hong Kong)1 facilitate the development by insurers of an insurance-linked securities (“ILS”) business in Hong Kong by providing for a streamlined regulatory framework for the authorisation of ‘special purpose insurers’ to carry on ‘special purpose business’. On the same date that the legislative amendments took effect, the subsidiary legislation governing the sale of ILS (the Insurance (Special Purpose Business) Rules (Cap. 41P, Laws of Hong Kong)) also came into operation.
The legislative amendments are part of the Hong Kong government’s initiative to promote Hong Kong as a preferred domicile for the issuance of ILS and to strengthen Hong Kong’s position as a global risk management centre and regional insurance hub.
What are ILS?
ILS are securities which securitise insurance risks and transfer such risks to investors in the capital markets, with catastrophe – or “cat” – bonds being the most significant form of ILS issued to date. Cat bonds package up the risk of having to pay out on insurance policies which cover, typically, large-scale natural disasters such as extreme weather conditions. They can also relate to the risk of other, non-natural catastrophes happening – for example, FIFA issued catastrophe bonds worth US$260 million to provide protection against the possibility of the 2002 FIFA World Cup being cancelled. Once packaged up as securities, those risks are then transferred to capital market investors, instead of the risks being ceded in a more conventional way to reinsurance companies.
Focussing on the simple structure which is used in a typical cat bond issuance, three key players are usually involved:
1. The insurance company (the ‘sponsor’) which is sponsoring the deal and is ceding risk.
2. A special purpose vehicle (established by the sponsor) which issues ILS. As with most securitisations, an SPV is used to issue the ILS so that it is immune to any potential financial distress of the sponsor, i.e. it is bankruptcy remote. Under the Hong Kong regime, this role would be performed by the ‘special purpose insurer’.
The sponsor and the SPV would enter into a risk transfer contract under which the sponsor pays a reinsurance premium to the SPV in order to reinsure its risk. The risk transfer contract is a contract similar in nature to a standard reinsurance contract, providing for terms such as the premiums to be paid, the duration of the deal, the risks that are to be ceded, the circumstances in which claims can be made and so on. The risk transfer contract does not have to be a reinsurance contract and can also be structured as a derivative.
If no predefined event occurs during the lifetime of the ILS, then the investors receive the principal payment in full at maturity. If, however, a covered event happens, then the SPV pays out to the sponsor in accordance with the terms of the risk transfer contract and uses the amounts available from the collateral account to do so. The balance is paid to investors, meaning that investors lose all or part of their principal under these circumstances.
Benefits of ILS
An SPV in an ILS issuance which carries on SPB in or from Hong Kong has to be authorised as a special purpose insurer (SPI) under the Insurance Ordinance. The SPV can be a Hong Kong-incorporated company or an overseasincorporated company registered under Part 16 of the Companies Ordinance. For it to be so authorised, it must carry on SPB only and not any other class of insurance business. Given the difference between the business of a SPI and that of a traditional insurer carrying on long term business or general business, the regulatory regime does not impose the same capital or solvency requirements on SPIs as are applied to other insurers. Instead, SPIs are required to be “fully funded”.
Interestingly, the IA has opened up the possibility for an SPI to be re-used for more than one ILS transaction. This must be declared in the initial application to the IA for authorisation. If so, the SPI must obtain confirmation from the IA that it has no objection before it enters into any risk transfer contract to be backed by a new ILS issuance. The IA expects the SPI to provide updated information and documents relating to the proposed new ILS transaction to ensure that requirements including the “fully-funded” condition will be complied with.
For further information, please contact:
Chin-Chong Liew, Partner, Linklaters
chin-chong.liew@linklaters.com